Literature DB >> 18394178

Cardiovascular and metabolic responses to catecholamine and sepsis prognosis: a ubiquitous phenomenon?

Solène Collin1, Nacira Sennoun, Bruno Levy.   

Abstract

Many parameters have been associated with sepsis prognosis. In the present issue of Critical Care, Kumar and colleagues demonstrate that a preserved cardiac answer to dobutamine evaluated by radionucleotide measurements was associated with a better prognosis during septic shock. In this context, it is interesting to note that not only is the cardiac response to catecholamine stimulation associated with prognosis, but also the vascular and metabolic responses are associated. The ability of exogenous catecholamine to increase the arterial pressure (dopamine test) or to increase the lactate level is also related to prognosis. According to the ubiquitous character of catecholamine sensitivity, therefore, we should think in terms of cellular ability to respond to catecholamines in defining the concept of physiological reserve.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18394178      PMCID: PMC2447558          DOI: 10.1186/cc6816

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


In the present issue of Critical Care, Kumar and colleagues [1] elegantly demonstrate using graded dobutamine challenge in septic shock patients combined with radionucleotide measurement of cardiac function that only the survivors were able to maintain cardiac responsiveness to dobutamine stimulation. In fact, the prognosis value of a positive response to dobutamine challenge has been already demonstrated in several studies, in which the answer to dobutamine was evaluated using different indices: the oxygen delivery/oxygen consumption relationship in Vallet and colleagues' study [2], or an increase in the cardiac index in the studies of Rhodes and colleagues [3] and of Jellema and colleagues [4]. It is interesting to note that not only is the cardiac response to catecholamine stimulation associated with the prognosis, but also the vascular and metabolic responses are associated. For example, it is well demonstrated that hemodynamic severity of septic shock is linked to the acuteness of vasoplegia. In animal models and human studies, vasoplegia is clearly related to hyporeactivity to exogenous and endogenous vasopressors (norepinephrine and vasopressin, for instance) [5]. Experimental and clinical data have demonstrated that, between the many factors involved, an overproduction of nitric oxide and peroxynitrite leading to the stimulation of vascular potassium channels is responsible for vascular hyporeactivity [6]. Despite this complicated pathophysiological network, it is possible to simply assess vascular reactivity and thus the septic shock prognosis using a dopamine test. We have previously demonstrated that dopamine-sensitive patients – for example, patients who were able to increase their mean arterial pressure with a maximal dose of 20 μg/kg/min dopamine – had a better prognosis (survival 78%) when compared with dopamine-resistant patients (survival 16%) [7]. At the least, the metabolic response can be evaluated by the ability to produce lactate. During septic shock, lactate production may be related not only to a hypoxic mechanism but also to an increased metabolic demand. Experimental data have demonstrated that lactate production in the muscle is linked to epinephrine stimulation of the Na+, K+-ATPase pump. In human septic shock, we also demonstrated that muscle was a net producer of lactate, and that this production could be totally inhibited by ouabain, thus confirming a Na+, K+-ATPase-dependent mechanism while clearly independent of tissue hypoxia [8]. Muscle tissue, which represents approximately 40% of the total body cell mass, is particularly implicated in this mechanism, notwithstanding that > 99% of muscle adrenergic receptors are β2 receptors. We recently demonstrated in low-flow (hemorrhagic) and normal-to-high-flow models of shock (endotoxin and peritonitis) that lactate production during shock states is related, at least in part, to increased Na+, K+-ATPase activity under β2 stimulation [9]. Levraut and colleagues, using an infusion of exogenous lactate to estimate lactate production and clearance, found in stable normolactatemic septic shock patients that survivors produced more lactate than nonsurvivors [10]. Similarly, the survivors were also better able to clear this overproduction of lactate. The response to catecholamine can therefore be studied at the heart level using β1 stimulation, at the vessel level using α stimulation, and at the metabolic level using β2 stimulation. It remains unknown, however, whether this disturbed answer to catecholamine response is due to a signaling problem at the receptor or postreceptor levels or due to the tissue's inability to produce the physiological answer, or both. To conclude, according to the ubiquitous character of catecholamine sensitivity, we should think in terms of cellular ability to respond to catecholamines in defining the concept of physiological reserve rather than in terms of preload or cardiac reserve.

Competing interests

The authors declare that they have no competing interests.
  10 in total

Review 1.  The pathogenesis of vasodilatory shock.

Authors:  D W Landry; J A Oliver
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

2.  Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients.

Authors:  Jacques Levraut; Carole Ichai; Isabelle Petit; Jean-Pierre Ciebiera; Olivier Perus; Dominique Grimaud
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

3.  A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock.

Authors:  A Rhodes; F J Lamb; I Malagon; P J Newman; R M Grounds; E D Bennett
Journal:  Crit Care Med       Date:  1999-11       Impact factor: 7.598

4.  Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study.

Authors:  Bruno Levy; Benjamin Dusang; Djillali Annane; Sebastien Gibot; Pierre-Edouard Bollaert
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

Review 5.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

6.  Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.

Authors:  Wilbert T Jellema; A B Johan Groeneveld; Karel H Wesseling; Lambertus G Thijs; Nico Westerhof; Johannes J van Lieshout
Journal:  Crit Care Med       Date:  2006-09       Impact factor: 7.598

7.  Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study.

Authors:  Bruno Levy; Sébastien Gibot; Patricia Franck; Aurélie Cravoisy; Pierre-Edouard Bollaert
Journal:  Lancet       Date:  2005 Mar 5-11       Impact factor: 79.321

8.  Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study.

Authors:  B Vallet; C Chopin; S E Curtis; B A Dupuis; F Fourrier; H Mehdaoui; B LeRoy; A Rime; C Santre; P Herbecq
Journal:  Crit Care Med       Date:  1993-12       Impact factor: 7.598

9.  Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states.

Authors:  Bruno Levy; Olivier Desebbe; Chantal Montemont; Sebastien Gibot
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

10.  Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock.

Authors:  Anand Kumar; Elizabeth Schupp; Eugene Bunnell; Amjad Ali; Barry Milcarek; Joseph E Parrillo
Journal:  Crit Care       Date:  2008-03-04       Impact factor: 9.097

  10 in total
  1 in total

1.  Molecular Mechanisms Linking Autonomic Dysfunction and Impaired Cardiac Contractility in Critical Illness.

Authors:  Gareth L Ackland; John Whittle; Andrew Toner; Asif Machhada; Ana Gutierrez Del Arroyo; Alberto Sciuso; Nicholas Jenkins; Alex Dyson; Richard Struthers; J Robert Sneyd; Gary Minto; Mervyn Singer; Ajay M Shah; Alexander V Gourine
Journal:  Crit Care Med       Date:  2016-08       Impact factor: 7.598

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.